Anhui Renji Pharmaceutical Co. Ltd.

Main study objectives To study the pharmacokinetics of the test preparation amlodipine besylate tablets (specification: 5 mg, produced and certified by Shanghai Huayuan Anhui Renji Pharmaceutical Co., Ltd.) and the reference preparation amlodipine besylate tablets (trade name: Norvasc®, specification: 5 mg, produced and certified by Pfizer Pharmaceutical Co., Ltd.) in healthy adult subjects after single oral administration in fasting and fed state, and to evaluate the bioequivalence of the two preparations after fasting and fed oral administration. Secondary study objectives To evaluate the safety of the test preparation (T) amlodipine besylate tablets and the reference preparation (R) amlodipine besylate tablets (Norvasc®) after single oral administration in fasting and fed state in healthy subjects.

A single-center, randomized, open-label, two-dose, single-dose, two-period, double-crossover fasting/fed bioequivalence study of cefaclor capsules in healthy subjects

The main purpose of the study is to study the pharmacokinetics of the test preparation Dienogest Tablets (Specification: 2mg, produced by Shanghai Huayuan Anhui Jinhui Pharmaceutical Co., Ltd.) and the reference preparation Dienogest Tablets (trade name: Visanne, specification: 2mg, certified by Jenapharm GmbH & CO.KG) in healthy adult female subjects after a single oral administration in the fasting/postprandial state, and to evaluate the bioequivalence of the two preparations in the fasting/postprandial state. Secondary purpose of the study: to observe the safety of the test preparation Dienogest Tablets and the reference preparation Dienogest Tablets (Visanne) in healthy adult female subjects.